<div class="section" id="vision">
    <h1>Vision</h1>
    <p>
      NAMetrics is established to advance and promote the research, development, and validation of 
      innovative <strong>in silico New Approach Methodologies (NAMs)</strong> by fostering <strong>collaboration between quantitative 
      and analytical pharmacologists</strong> in the pursuit of advancing drug discovery and development.
    </p>
  </div>
<br>
<div class="team-member" style="display: flex; align-items: center;">
  <img src="Krina_pict.png" style="max-width: 20%; height: auto; margin-right: 20px;">
  <div>
    <p class="name"><strong>Krina Mehta, PhD, Founder</strong> </p>
    <p>
      Krina is a quantitative pharmacologist with over 15 years of experience. Her work specializes in 
      pharmacometrics and translational pharmacology, currently serving as Director at Kyowa Kirin Inc., 
      where she leads strategy and modeling efforts across various therapeutic areas including oncology 
      and rare diseases. Krina has deep expertise in modeling approaches such as PopPK, PBPK, QSP, and 
      semi-mechanistic modeling. She holds a PhD in Quantitative Pharmacology, along with an MS in 
      Pharmacometrics and a BPharm. Her work is reflected in several peer-reviewed publications and 
      conference presentations, and she actively serves on several professional communities, like ISOP 
      and ASCPT. Krina is especially passionate about modernizing drug discovery and development while 
      reducing animal use in pharmacology evaluations.
    </p>
  </div>
</div>
